Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls
NCT03602599 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2026-04-14
Summary
Background:
This study follows people who have had, or will soon have, a transplant using stem cells from another person. This is known as an allogeneic hematopoietic stem cell transplant (HSCT). Graft-versus-host disease (cGVHD) can happen after HSCT. cGVHD can cause mouth problems and more serious issues. Researchers want to study changes in the mouth that might indicate cGVHD.
Objective:
To identify cGVHD in the mouth and better understand the development, treatment, and progress of post-transplant changes in the mouth.
Eligibility:
Adults at least 18 years old who will soon undergo HSCT or have had one in the past 3 years Healthy adults at least 18 years old
Design:
All participants will have a screening visit and baseline visit. They will last 60-90 minutes. Over these two visits, participants will have:
Medical and dental history
Dental exam.
Questions about their eating habits and general health
Blood drawn through a needle in the arm
Vital signs taken
Pictures of their mouth and lips taken
Questions about their oral health, including about pain, sensitivity, or dryness
Saliva samples taken. Participants will spit into a sterile plastic tube.
Swabs taken of the mouth and some of the saliva, plaque, and fluid from the spaces between teeth and gums.
Participants may also have:
A piece of skin taken (biopsy) from the inner lining of the cheeks
A piece of skin taken (biopsy) from the lower lip
Dental X-rays
Urine pregnancy test
Most participants will have at least 7 study visits over 3 years. They will meet with a dentist and repeat baseline tests.
Conditions
Sponsors & Collaborators
-
National Institute of Dental and Craniofacial Research (NIDCR)
lead NIH
Principal Investigators
-
Jacqueline W Mays, D.D.S. · National Institute of Dental and Craniofacial Research (NIDCR)
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-11-15
- Primary Completion
- 2037-03-03
- Completion
- 2037-03-03
Countries
- United States
Study Locations
More Related Trials
-
Study of the Complications Associated With Certain Stem Cell Transplants
NCT01919099 ·Status: COMPLETED
-
Effectiveness of the Hepatitis B Vaccine Post-Hematopoietic Stem Cell Transplant
NCT03511794 ·Status: COMPLETED
-
Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease
NCT00092235 ·Status: RECRUITING
-
Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases
NCT06294691 ·Status: RECRUITING ·Phase: PHASE3
-
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
NCT01206309 ·Status: COMPLETED
-
Experience of Having Chronic Graft-Versus-Host Disease
NCT00353106 ·Status: COMPLETED
-
Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
NCT00003538 ·Status: COMPLETED ·Phase: NA
-
Modification of the Human Colon and Oral Microbiome by Allogenic HSCT
NCT03942159 ·Status: UNKNOWN
-
Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation
NCT06649201 ·Status: RECRUITING
-
Bone Marrow Stromal Cell Infusions for Stem Cell Transplant Complications
NCT01633229 ·Status: COMPLETED ·Phase: PHASE1
-
The Association of Microbiota Composition With cGVHD After Allo-HSCT
NCT05355675 ·Status: UNKNOWN
-
Impact of Oral Nutritional Supplements on Patients Undergoing Haematopoietic Stem Cell Transplantation
NCT05460013 ·Status: COMPLETED ·Phase: NA
-
Immune Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation
NCT03233659 ·Status: COMPLETED
-
Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation
NCT03000244 ·Status: RECRUITING
-
Evaluation of Toxicity From Stem Cell Transplant
NCT00631787 ·Status: COMPLETED
-
Cardiomyopathy Following Stem Cell Transplantation
NCT00352209 ·Status: COMPLETED
-
Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies
NCT06294678 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant
NCT05722210 ·Status: NOT_YET_RECRUITING
-
Retrospective Study of Viral Reactivation Across All Bone Marrow Transplant Protocols Since 2010
NCT03111745 ·Status: COMPLETED
-
Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT
NCT04629430 ·Status: COMPLETED ·Phase: NA
-
Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease
NCT02194439 ·Status: COMPLETED
-
Alterations in Intestinal Microbiota, Metabolites, and Immune Cells in Allo-HSCT
NCT06143501 ·Status: RECRUITING
-
Quality of Life in Patients Who Have Undergone Stem Cell Transplant
NCT00128960 ·Status: COMPLETED
-
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia
NCT00001623 ·Status: COMPLETED ·Phase: NA
-
Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation
NCT06093867 ·Status: RECRUITING